Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...]
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/7/1526 |
_version_ | 1797443112877948928 |
---|---|
author | Niklas Jäger Markus Hoffmann Stefan Pöhlmann Nadine Krüger |
author_facet | Niklas Jäger Markus Hoffmann Stefan Pöhlmann Nadine Krüger |
author_sort | Niklas Jäger |
collection | DOAJ |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...] |
first_indexed | 2024-03-09T12:51:25Z |
format | Article |
id | doaj.art-e288826b15b84f25a7e28ff19b282c41 |
institution | Directory Open Access Journal |
issn | 1999-4915 |
language | English |
last_indexed | 2024-03-09T12:51:25Z |
publishDate | 2022-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Viruses |
spelling | doaj.art-e288826b15b84f25a7e28ff19b282c412023-11-30T22:05:39ZengMDPI AGViruses1999-49152022-07-01147152610.3390/v14071526Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177Niklas Jäger0Markus Hoffmann1Stefan Pöhlmann2Nadine Krüger3Infection Biology Unit, German Primate Center–Leibniz Institute for Primate Research, 37077 Göttingen, GermanyInfection Biology Unit, German Primate Center–Leibniz Institute for Primate Research, 37077 Göttingen, GermanyInfection Biology Unit, German Primate Center–Leibniz Institute for Primate Research, 37077 Göttingen, GermanyInfection Biology Unit, German Primate Center–Leibniz Institute for Primate Research, 37077 Göttingen, GermanySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...]https://www.mdpi.com/1999-4915/14/7/1526n/a |
spellingShingle | Niklas Jäger Markus Hoffmann Stefan Pöhlmann Nadine Krüger Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 Viruses n/a |
title | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 |
title_full | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 |
title_fullStr | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 |
title_full_unstemmed | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 |
title_short | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. <i>Viruses</i> 2022, <i>14</i>, 177 |
title_sort | nafamostat mediated inhibition of sars cov 2 ribosomal frameshifting is insufficient to impair viral replication in vero cells comment on munshi et al identifying inhibitors of 1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses i viruses i 2022 i 14 i 177 |
topic | n/a |
url | https://www.mdpi.com/1999-4915/14/7/1526 |
work_keys_str_mv | AT niklasjager nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesivirusesi2022i14i177 AT markushoffmann nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesivirusesi2022i14i177 AT stefanpohlmann nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesivirusesi2022i14i177 AT nadinekruger nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesivirusesi2022i14i177 |